MedPath

The Effects of the Novel Unloading Device "HEPHAISTOS" on Bone, Muscles and Vessels

Not Applicable
Completed
Conditions
Muscle; Atrophy, General
Interventions
Device: Hephaistos unloading orthosis
Registration Number
NCT03086187
Lead Sponsor
DLR German Aerospace Center
Brief Summary

11 healthy men used the HEPHAISTOS unloading orthosis in an ambulatory 8 week intervention study.

It greatly reduces calf muscle forces without reducing ground reaction forces.

Detailed Description

The 56day unloading intervention with HEPHAISTOS had the following key objectives:

1. Primary objective: Assessment and evaluation of bone adaptation.

2. Secondary objective: Assessment and evaluation of functional and structural muscular adaptations.

3. Third objective: Assessment and evaluation of functional and structural vascular adaptations.

4. Fourth objective: Assessment and evaluation if the present findings deviate from findings observed in established unloading models.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
11
Inclusion Criteria
  • male
  • age: 20-45
  • BMI: 20-30
Exclusion Criteria
  • smoking
  • professional sports men
  • diabetes
  • rheumatism
  • muscle and joint disease
  • bone fractures within 12 months prior to the study
  • cruciate ligament rupture within 10 years prior to the study
  • metal implants
  • participation in any other clinical study within 2 months prior to the study haemophilia
  • any blood vessel disease
  • epilepsy
  • claustrophobia
  • herniated disk
  • cardiac pulse generator
  • drug or alcohol abuse
  • hyperlipidaemia
  • kidney disease
  • hyperhomocysteaemia
  • hyper/hypouricemia
  • hyper/hypocalcaemia
  • anaemia
  • vitamin d deficit
  • chronical back pain
  • deficient certificate of good conduct
  • achilles tendon injury

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Hephaistos unloading orthosisHephaistos unloading orthosisHephaistos unloading orthosis: Calf muscle unloading: The 11 male subjects had to wear a novel orthosis for 8 weeks, which greatly reduces plantarflexor forces during gait.
Primary Outcome Measures
NameTimeMethod
Bone density as measured with pQCTAt baseline and up to 12 months after the immobilization phase

Change from baseline to 14 days after immobilization phase

Secondary Outcome Measures
NameTimeMethod
Structural and functional parameters of arterial adaptationAt baseline and up to 12 months after the immobilization phase

Change in flow-mediated dilation

Trial Locations

Locations (1)

German Aerospace Center

🇩🇪

Cologne, North Rine Westphalia, Germany

© Copyright 2025. All Rights Reserved by MedPath